Article Type

1 - 15 of 146 Results       Clear All

Bay Area Researchers Develop New Rapid COVID-19 Test That Uses Smartphone Camera

Gladstone in the News January 15, 2021

Bay Area Researchers Develop New Rapid COVID-19 Test That Uses Smartphone Camera

ABC7 News—Gladstone Institute of Virology Director Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni comment on the COVID-19 detection test they recently developed with Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD, using CRISPR and smartphone technology.

Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Can CRISPR-Based COVID-19 Testing Using Smartphones Slow the Pandemic?

Gladstone in the News December 13, 2020

Can CRISPR-Based COVID-19 Testing Using Smartphones Slow the Pandemic?

Forbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab

COVID Test May Be as Close as Your Smartphone, Say UC, Gladstone Researchers

Gladstone in the News December 11, 2020

COVID Test May Be as Close as Your Smartphone, Say UC, Gladstone Researchers

San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab

Does COVID-19 Result in Lasting Immunity? Growing Evidence Says Yes

Gladstone in the News November 18, 2020

Does COVID-19 Result in Lasting Immunity? Growing Evidence Says Yes

San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on recent findings by her group and others that COVID-19 patients retain immune cells against the new coronavirus for several months after infection, which bodes well for the ability of vaccines to provide lasting protection against the disease.

Gladstone Experts COVID-19 Virology Roan Lab

Fast, Cheap, Accurate: Researchers Pin Hopes on Nobel Prize–Winning CRISPR Technology to Detect Coronavirus

Gladstone in the News October 28, 2020

Fast, Cheap, Accurate: Researchers Pin Hopes on Nobel Prize–Winning CRISPR Technology to Detect Coronavirus

USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Fetal Tissue Research, Donald Trump, and the Science behind the Politics

Gladstone in the News October 18, 2020

Fetal Tissue Research, Donald Trump, and the Science behind the Politics

San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.

Gladstone Experts COVID-19 Virology Greene Lab

Conservatives Confront Moral Dilemma of Vaccines and Treatments Derived from Fetal Tissue Cells

Gladstone in the News October 18, 2020

Conservatives Confront Moral Dilemma of Vaccines and Treatments Derived from Fetal Tissue Cells

ABC News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.

Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media